News tagged with 'Biederman'

Georgetown University discussed the potential for a conflict-of-interest between doctors and pharmaceutical companies that partially fund continuing-education for doctors.

A nonprofit representing 32 medical societies has released a new code of ethics that stresses disclosure of financial conflicts from drug and device makers by doctors and medical journalists.

Universities are often not told about the money their academics receive from device makers as consultants and product developers.

Young people in Eastern Iowa appear to be overdosing on prescription drugs for ADHD. About 2.5 million kids are on the stimulants, with use increasing, despite a recently published article that suggests a link between the medications and sudden cardiac death. 

Amid embarassing revelations that members of the American Psychiatric Association have taken and not revealed drug industry funding, the APA says it will shun sponsored symposia and meals - it just doesn't say when.

The deposition of Harvard psychiatrist Dr. Joseph Biederman, shows that he promises Johnson & Johnson executives positive results of a clinical trial on an antipsychotic, before the study even took place.

Pfizer plans to become the first drugmaker to disclose on its web site the lucrative payments it makes to doctors who promote and research its drugs. The move is intended to promote transparency and regain the trust of the public after revelations that some academics on the take were not disclosing the relationship.

After the public embarassment at Harvard Medical School concerning faculty on the receiving end of lucrative consulting fees, the school and its teaching facilities are revisiting and revising conflict-of-interest policies.  

More information is surfacing about conflicting interests involving a Harvard psychiatrist, renowned for promoting antipsychotics, and the research center that bears the name of Johnson & Johnson, which he heads.